Welcome to HCV Advocate’s hepatitis blog. The intent of this blog is to keep our website audience up-to-date on information about hepatitis and to answer some of our web site and training audience questions. People are encouraged to submit questions and post comments.

For more information on how to use this blog
, the HCV drug pipeline, and for more information on HCV clinical trials click here

Be sure to check out our other blogs: The HBV Advocate Blog and Hepatitis & Tattoos.

Alan Franciscus
HCV Advocate
HBV Advocate

Thursday, November 3, 2011

Putting an end to viral hepatitis: America’s silent killer

By Congressman Michael Honda (D-Calif.) and Senator John Kerry (D-Mass.) - 11/03/11 10:36 AM ET
There’s a silent killer loose in America.  It is viral hepatitis, and it contributes to the death of 15,000 Americans every year. Most people don’t even know they have it until years later when it’s too late for any treatment to work.

That is why we’re fighting back with new legislation being introducing today: the Viral Hepatitis Testing Act of 2011, the start of what we expect to be a historic national effort to fight – and ultimately eradicate – Hepatitis B (HBV) and C (HCV) in America.  The current approach is not working.  Typically, despite the pervasive nature of Hepatitis B and C, health providers do not screen Americans at high-risk for hepatitis.  Moreover, most people don’t recognize symptoms until later stages when they have developed cancer or liver disease.


No comments:

Post a Comment